This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Desensitization to allergens
Z21_DESEN_ALLERGE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2329 |
4. Check minimum number of eventsNone |
2329 |
5. Include endpointsNone |
2329 |
6. Filter based on genotype QC (FinnGen only) |
2329 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- HYPOSENSIBILIZATIONTHRPY
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z51
Similar endpoints
↥List of similar endpoints to
Desensitization to allergens
based on the number of shared cases.
Similar with more cases:
- Other medical care
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2329 | 1575 | 754 |
| Unadjusted period prevalence (%) | 0.47 | 0.54 | 0.33 |
| Median age at first event (years) | 31.48 | 31.88 | 30.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2054
- Matched controls
- 20538
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XQ800
NOMESCO Finland
Prick test
11.5
323.0
783
1041
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
98.3
323.0
1685
914
C01CA24
ATC
epinephrine; parenteral
43.8
323.0
1292
765
Z51.6
ICD-10 Finland
Desensitization to allergens
+∞
323.0
2054
6
J45.0
ICD-10 Finland
Predominantly allergic asthma
13.7
323.0
901
1110
S01GX01
ATC
cromoglicic acid; ophthalmic
12.0
323.0
1386
3025
WQ000
NOMESCO Finland
Hyposensibilisation
345.2
323.0
642
27
H02AB06
ATC
prednisolone; systemic
6.3
322.3
1431
5477
R06AE07
ATC
cetirizine; oral
6.3
303.7
1580
7105
R06AX27
ATC
desloratadine; oral
5.8
297.4
1294
4645
R03AC02
ATC
salbutamol; inhalant
6.3
286.2
1658
8181
R03DC03
ATC
montelukast; oral
6.5
261.2
833
1956
V01AA05
ATC
tree pollen; parenteral
43.8
233.7
291
77
V01AA02
ATC
grass pollen; systemic
104.4
228.2
248
27
J30.3
ICD-10 Finland
Other allergic rhinitis
12.9
221.4
416
397
R06AE09
ATC
levocetirizine; oral
5.5
216.6
785
2065
R06AX13
ATC
loratadine; oral
5.3
208.1
789
2167
R01AD08
ATC
fluticasone; nasal
4.4
203.3
1053
3966
R06AX22
ATC
ebastine; oral
5.3
203.2
770
2103
R03BA02
ATC
budesonide; inhalant
5.1
190.8
746
2082
SPAT1267
SPAT
Desensitisation
194.6
188.5
194
11
R01AD09
ATC
mometasone; nasal
4.0
185.4
1400
7173
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.9
182.0
722
2028
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
4.1
173.9
910
3320
3023
Kela drug reimbursment
Allergen extract of birch pollen (adults)
101.6
153.7
168
18
R97
ICPC
Allergic rhinitis
12.4
149.3
282
261
S01GX02
ATC
levocabastine; ophthalmic
7.1
148.1
396
667
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
5.2
144.4
510
1218
XG410
NOMESCO Finland
Flow-volume spirometry
12.1
143.4
273
256
R01AD12
ATC
fluticasone furoate; nasal
3.3
138.9
1046
4879
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
9.3
136.0
301
374
J45.9
ICD-10 Finland
Asthma, unspecified
4.2
130.3
594
1817
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
7.8
120.8
298
438
R06AX26
ATC
fexofenadine; oral
5.7
116.3
371
770
R03BA05
ATC
fluticasone; inhalant
3.6
114.2
648
2347
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
113.2
502
1471
XG474
NOMESCO Finland
Exhalation nntrogen oxide
10.2
112.2
233
255
J30.19
ICD-10 Finland
Pollen allergy UNS
7.5
112.1
282
425
R03AC03
ATC
terbutaline; inhalant
3.9
105.3
504
1570
A92
ICPC
Allergy/allergic reaction NOS
7.4
102.9
261
396
L20.0
ICD-10 Finland
Besnier prurigo
4.1
94.5
426
1245
R01AD01
ATC
beclometasone; nasal
3.7
93.7
487
1608
R01AD05
ATC
budesonide; nasal
5.0
93.5
328
747
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
7.2
90.3
233
360
R01AC01
ATC
cromoglicic acid; nasal
6.1
89.0
259
471
E0000UV
ATC
NA
2.5
82.7
1049
6066
R03AK07
ATC
formoterol and budesonide; inhalant
3.1
81.2
555
2218
J45
ICD-10 Finland
Asthma
4.1
78.6
344
966
364
Kela drug reimbursment
Allergen extract of birch pollen and allergen extract of grass pollen
89.8
77.6
86
10
T78.4
ICD-10 Finland
Allergy, unspecified
4.9
74.9
263
592
R03BA01
ATC
beclometasone; inhalant
3.5
73.2
387
1270
S01GX08
ATC
ketotifen; ophthalmic
6.1
72.2
208
370
Z3231
NOMESCO Finland
Registered nurse
2.6
68.5
660
3200
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
12.9
68.3
124
102
R01BA52
ATC
pseudoephedrine, combinations; oral
2.6
68.0
657
3187
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.5
68.0
362
1189
J30.1
ICD-10 Finland
Allergic rhinitis due to pollen
47.4
67.3
82
18
H02AB07
ATC
prednisone; oral
3.4
60.5
333
1114
R03BA08
ATC
ciclesonide; inhalant
4.0
60.4
267
746
T63.4
ICD-10 Finland
Toxic effect: Venom of other arthropods
16.5
58.4
95
60
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
8.2
58.3
135
175
R01AD11
ATC
triamcinolone; nasal
3.6
57.8
289
895
D07AB08
ATC
desonide; topical
3.1
54.6
335
1206
R06AX12
ATC
terfenadine; oral
4.7
54.0
195
447
E000001
ATC
NA
2.3
53.3
598
3060
H02AB04
ATC
methylprednisolone; systemic
3.1
52.5
331
1210
R96
ICPC
Asthma
3.6
50.6
245
735
S01GX09
ATC
olopatadine; ophthalmic
6.5
49.8
135
220
E000002
ATC
NA
2.7
49.8
392
1650
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.1
45.0
149
310
J30.0
ICD-10 Finland
Vasomotor rhinitis
7.0
43.4
111
167
R03AC13
ATC
formoterol; inhalant
5.3
42.7
137
275
L27.2
ICD-10 Finland
Dermatitis due to ingested food
6.5
41.8
112
180
J45.8
ICD-10 Finland
Mixed asthma
5.9
41.6
120
212
R01AC02
ATC
levocabastine; nasal
5.0
41.4
140
298
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.6
41.4
341
1460
R03AK08
ATC
formoterol and beclometasone; inhalant
5.4
41.4
130
255
R06AX18
ATC
acrivastine; oral
6.4
40.9
111
181
D07AA02
ATC
hydrocortisone; topical
2.3
39.0
430
2137
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
8.4
38.8
87
107
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
4.1
38.0
158
413
R03AC12
ATC
salmeterol; inhalant
5.6
37.7
114
214
R06AX11
ATC
astemizole; oral
4.2
37.3
147
366
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.7
36.7
131
295
D11AH01
ATC
tacrolimus; topical
8.4
36.1
81
100
D07AC01
ATC
betamethasone; topical
2.0
35.7
620
3713
J01FA10
ATC
azithromycin; systemic
1.8
34.7
1409
11197
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
4.7
33.8
120
269
R06.2
ICD-10 Finland
Wheezing
3.8
32.9
145
399
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.2
32.3
177
580
D07AC13
ATC
mometasone; topical
1.9
31.9
565
3381
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
31.3
573
3465
L50.0
ICD-10 Finland
Allergic urticaria
4.6
30.0
107
241
S01GX05
ATC
lodoxamide; ophthalmic
9.2
28.0
59
66
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.6
27.9
100
227
J31.0
ICD-10 Finland
Chronic rhinitis
2.7
27.8
202
795
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.7
27.7
206
822
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.2
27.6
297
1439
R03BB04
ATC
tiotropium bromide; inhalant
3.6
27.2
126
362
XQ802
NOMESCO Finland
Epicutan test
3.4
25.9
133
415
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
25.6
413
2359
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
25.1
1127
8778
ZX112
NOMESCO Finland
Subcutaneous
6.9
25.0
63
94
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
8.5
24.6
54
65
E000007
ATC
NA
2.7
24.6
176
685
S01GX04
ATC
nedocromil; ophthalmic
5.9
24.6
70
123
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.7
24.3
109
305
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
24.2
171
662
N05BB01
ATC
hydroxyzine; systemic
2.7
24.0
168
645
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
23.3
563
3667
J01FA06
ATC
roxithromycin; oral
1.7
23.2
687
4747
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
8.6
22.6
49
58
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
22.0
120
391
D02AE01
ATC
carbamide; topical
2.7
22.0
153
584
R03DA04
ATC
theophylline; systemic, rectal
4.2
21.8
85
210
D11AX14
ATC
[U] tacrolimus; topical
9.5
21.6
44
47
J46
ICD-10 Finland
Status asthmaticus
4.7
21.6
75
166
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.7
21.5
148
564
L20
ICD-10 Finland
Atopic dermatitis
3.1
21.2
118
391
R03BC01
ATC
cromoglicic acid; inhalant
4.6
20.7
73
164
R03BC03
ATC
nedocromil; inhalant
2.8
20.4
140
530
DHB50
NOMESCO Finland
Turbinoplasty
3.7
20.2
90
251
R03AK11
ATC
formoterol and fluticasone; inhalant
4.6
19.7
69
154
J01AA02
ATC
doxycycline; systemic
1.5
19.5
1287
10694
D11AH02
ATC
pimecrolimus; topical
9.2
19.4
40
44
R06.0
ICD-10 Finland
Dyspnoea
1.8
19.3
355
2105
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
18.8
322
1861
J32.4
ICD-10 Finland
Chronic pansinusitis
6.2
18.7
50
82
D02AX
ATC
Other emollients and protectives
3.0
18.5
108
371
XQ899
NOMESCO Finland
Other assessment of skin
13.7
18.2
31
23
X27
ICD-10 Finland
Contact with other specified venomous animals
25.3
18.2
25
10
J01FA09
ATC
clarithromycin; systemic
1.6
18.2
621
4393
S01GX06
ATC
emedastine; ophthalmic
5.6
18.0
52
94
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
3.9
17.9
74
194
R03CC02
ATC
salbutamol; systemic
1.9
17.7
301
1731
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
17.7
515
3492
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.7
17.2
76
212
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
9.8
16.7
33
34
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
16.4
410
2658
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
16.3
356
2219
E000006
ATC
NA
2.4
16.2
143
625
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.6
16.1
74
213
J33.8
ICD-10 Finland
Other polyp of sinus
4.8
16.1
53
112
J34.2
ICD-10 Finland
Deviated nasal septum
2.7
15.9
110
420
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
5.4
15.9
47
88
X48
ICD-10 Finland
Accidental poisoning by and exposure to pesticides
161.2
15.5
16
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.9
15.0
62
164
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
14.7
443
3011
D07CC01
ATC
betamethasone and antibiotics; topical
1.9
14.5
234
1318
J30.2
ICD-10 Finland
Other seasonal allergic rhinitis
10.1
14.4
28
28
A02BC05
ATC
esomeprazole; systemic
1.5
14.4
585
4268
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.8
13.9
275
1657
XG405
NOMESCO Finland
Education on PEF monitoring
5.3
13.8
41
78
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
3.1
13.7
74
242
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
3.5
13.7
63
183
J02AC01
ATC
fluconazole; systemic
1.5
13.6
757
5885
D11AX15
ATC
[U] pimecrolimus; topical
11.0
13.5
25
23
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
13.5
1110
9295
E000003
ATC
NA
2.5
13.4
109
457
A02BC01
ATC
omeprazole; systemic
1.6
13.3
373
2483
J05AB01
ATC
aciclovir; systemic
1.6
13.0
356
2350
49300
ICD-8 Finland
Asthma, bronchiale
4.7
12.9
43
93
R03DC01
ATC
zafirlukast; oral
6.4
12.9
33
52
M01AE02
ATC
naproxen; oral, rectal
1.4
12.7
1135
9598
J01DB01
ATC
cefalexin; oral
1.5
12.6
1591
14355
R01AC07
ATC
nedocromil; nasal
10.1
12.5
24
24
WZC30
NOMESCO Finland
Teaching
1.9
12.5
188
1034
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
12.4
97
400
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
12.3
462
3289
R01AC03
ATC
azelastine; nasal
11.7
12.3
22
19
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
16.0
12.1
19
12
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
13.5
11.9
20
15
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
8.0
11.8
26
33
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
16.5
11.7
18
11
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
6.9
11.6
28
41
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
11.6
309
2024
J01AA04
ATC
lymecycline; systemic
1.6
11.5
310
2033
A12
ICPC
ALLERGY/ALLERGIC REACTION
7.2
11.5
27
38
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
9.3
11.5
23
25
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
3.3
11.5
57
177
SPAT1324
SPAT
Screening procedure
0.6
11.3
170
2751
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
5.8
11.3
31
54
Z2221
NOMESCO Finland
Medical doctor
1.5
11.3
503
3710
SPAT1058
SPAT
PEF monitoring instruction
2.1
11.1
133
669
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
10.9
144
756
R03BB01
ATC
ipratropium bromide; inhalant
4.3
10.8
39
93
XQ820
NOMESCO Finland
Exposure to medicinal substance
9.6
10.7
21
22
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.8
10.7
198
1168
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
5.0
10.6
33
67
-55
ICPC
Local injection/infiltration
11.3
10.5
19
17
X57
ICD-10 Finland
Unspecified privation
3.3
10.5
51
157
V01AA03
ATC
house dust mites
110.6
10.4
11
*
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
3.9
10.4
41
106
T78.3
ICD-10 Finland
Angioneurotic oedema
4.3
10.4
37
87
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
10.3
275
1800
W84
ICD-10 Finland
Unspecified threat to breathing
10.6
10.3
19
18
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.7
10.2
66
246
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.8
9.9
176
1024
SPAT1057
SPAT
Peak expiratory flow measurement
3.4
9.9
46
137
A98
ICPC
Health maint/preventive medicine
2.5
9.9
2014
19562
A02BC04
ATC
rabeprazole; oral
2.0
9.7
131
690
J37.0
ICD-10 Finland
Chronic laryngitis
3.0
9.7
53
178
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.8
9.6
60
218
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
9.5
89
402
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.4
9.5
81
351
XQ830
NOMESCO Finland
Exposure to foodstuff
15.1
9.5
15
10
A02BC02
ATC
pantoprazole; systemic
1.3
9.3
928
7825
S87
ICPC
Dermatitis/atopic eczema
2.6
9.2
67
268
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
9.1
241
1571
WX002
NOMESCO Finland
Sedation and analgesia
1.6
9.1
237
1539
M79.6
ICD-10 Finland
Pain in limb
1.4
9.0
553
4303
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
9.0
680
5479
J05AB11
ATC
valaciclovir; oral
1.6
9.0
210
1327
UDM02
NOMESCO Finland
Sinoscopy
3.0
8.9
49
166
H10.4
ICD-10 Finland
Chronic conjunctivitis
5.5
8.9
25
46
M02AA07
ATC
piroxicam; topical
1.4
8.9
412
3045
R05
ICD-10 Finland
Cough
1.5
8.8
302
2099
J01DC02
ATC
cefuroxime; systemic
2.0
8.8
111
572
ZXC60
NOMESCO Finland
Application of heat
3.6
8.6
37
104
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
3.7
8.6
36
99
L50.9
ICD-10 Finland
Urticaria, unspecified
2.2
8.6
85
396
M25.5
ICD-10 Finland
Pain in joint
1.4
8.6
481
3681
DPA30
NOMESCO Finland
Sphenotomy
7.0
8.5
20
29
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
8.5
180
1107
R02
ICPC
Shortness of breath/dyspnoea
1.7
8.5
175
1068
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
8.4
318
2254
J01AA07
ATC
tetracycline; systemic
1.5
8.4
323
2300
WQ034
NOMESCO Finland
NA
+∞
8.3
8
*
R49.01
ICD-10 Finland
Functional dysphonia
2.8
8.3
50
180
XQ801
NOMESCO Finland
Intracutantest
10.8
8.3
15
14
J02AC02
ATC
itraconazole; systemic
1.5
8.2
256
1736
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
8.2
565
4477
X58
ICD-10 Finland
Exposure to other specified factors
1.5
8.1
269
1853
344
Kela drug reimbursment
Omalizumab
22.1
8.0
11
5
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
6.3
8.0
20
32
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
8.0
279
1942
R06AE08
ATC
NA
4.8
7.9
25
53
L50.8
ICD-10 Finland
Other urticaria
3.1
7.8
40
130
DHB20
NOMESCO Finland
Polypectomy of internal nose
3.8
7.6
30
79
R01BA01
ATC
phenylpropanolamine; oral
2.1
7.6
85
419
395
Kela drug reimbursment
Dupilumab
25.1
7.6
10
*
H10
ICD-10 Finland
Conjunctivitis
1.8
7.5
130
750
D07AC14
ATC
methylprednisolone aceponate; topical
2.1
7.5
80
389
T63.8
ICD-10 Finland
Toxic effect: Toxic effect of contact with other venomous animals
80.4
7.4
8
*
R29
ICPC
Respiratory symptom/complaint other
1.8
7.4
113
629
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.5
7.4
308
2224
R74
ICPC
Upper respiratory infection acute
1.3
7.4
720
5990
M03BX02
ATC
tizanidine; oral
1.3
7.4
1034
9039
4222
FHL
Endonasal etmoidectomy
8.4
7.3
15
18
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
7.3
493
3880
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
7.3
341
2518
M79.1
ICD-10 Finland
Myalgia
1.5
7.2
232
1582
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
7.2
223
1509
R04
ICPC
Breathing problem other
2.5
7.2
52
210
J01FA15
ATC
telithromycin; oral
1.7
7.2
151
926
R06AX25
ATC
mizolastine; oral
7.9
7.1
15
19
J20
ICD-10 Finland
Acute bronchitis
1.7
7.1
140
844
J01MA06
ATC
norfloxacin; oral
1.6
7.1
166
1049
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
5.3
7.1
20
38
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
3.9
7.1
27
70
D06BX01
ATC
metronidazole; topical
1.7
7.1
148
908
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.0
590
4800
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
1.7
7.0
137
823
M01AB01
ATC
indometacin; systemic, rectal
2.5
6.9
52
214
D07AD01
ATC
clobetasol; topical
1.5
6.9
209
1411
TUPEI
NOMESCO Finland
NA
1.9
6.8
92
491
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.7
6.7
145
896
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
6.7
70
338
R03DX05
ATC
omalizumab; parenteral
22.6
6.7
9
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
6.6
172
1121
D07BC01
ATC
betamethasone and antiseptics; topical
1.6
6.6
158
1008
M01AH05
ATC
etoricoxib; oral
1.3
6.6
902
7821
L20.8
ICD-10 Finland
Other atopic dermatitis
3.4
6.5
29
86
S01AD03
ATC
aciclovir; ophthalmic
2.2
6.4
58
263
R05FB02
ATC
cough suppressants and expectorants
1.3
6.4
435
3422
J01CA04
ATC
amoxicillin; systemic
1.3
6.3
1688
15906
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
1.9
6.3
90
491
V01AA07
ATC
insects; oral
+∞
6.3
6
*
R4110
NOMESCO Finland
Physiotherapy
1.4
6.2
351
2677
R03AA01
ATC
epinephrine; inhalant
26.8
6.2
8
*
ZXA10
NOMESCO Finland
Bilateral
1.5
6.2
234
1652
E000004
ATC
NA
2.4
6.2
48
202
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.4
6.2
48
203
J01FA01
ATC
erythromycin; systemic
1.4
6.1
305
2276
L50.3
ICD-10 Finland
Dermatographic urticaria
2.7
6.1
38
142
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
6.1
400
3120
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
3.5
6.1
26
75
J32
ICD-10 Finland
Chronic sinusitis
4.7
6.1
19
41
J01DA06
ATC
[U] cefuroxime; systemic
1.5
6.1
225
1585
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
6.0
132
822
SPAT1268
SPAT
Allergy testing
6.7
6.0
14
21
R49.08
ICD-10 Finland
Other specified dysphonia
2.7
6.0
37
138
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3010726) Horse dander IgE Ab [Units/volume] in Serum
455
634
8.68
320.14
1.1
1.1
u/ml
2.4
2.6
0.11
171
167
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
475
722
8.01
309.59
1.2
1.1
u/ml
2.2
1.9
0.14
289
309
(3003888) Timothy IgE Ab [Units/volume] in Serum
513
656
9.75
307.65
1.1
1.1
u/ml
10.0
7.2
1.92
405
371
(3008401) Mugwort IgE Ab [Units/volume] in Serum
420
633
7.87
274.43
1.1
1.1
u/ml
1.7
1.2
0.50
306
285
(3014133) Dog dander IgE Ab [Units/volume] in Serum
337
532
7.24
209.11
1.1
1.0
u/ml
6.4
4.3
0.89
194
218
(3005322) IgE [Units/volume] in Serum or Plasma
579
1522
4.73
206.14
1.6
1.3
u/ml
597.4
208.5
3.05
562
1412
(3023430) Cat dander IgE Ab [Units/volume] in Serum
309
492
7.09
189.65
1.1
1.0
u/ml
7.3
5.5
0.70
201
216
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
269
451
6.61
156.33
1.1
1.0
u/ml
0.7
0.4
0.39
105
110
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
133
115
12.21
130.83
1.1
1.0
u/ml
14.7
6.1
—
38
9
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
105
77
14.23
113.94
1.2
1.1
u/ml
7.0
5.9
0.10
78
58
(3019420) Tryptase [Mass/volume] in Serum or Plasma
121
138
9.19
97.76
1.4
1.5
ug/l
5.6
7.4
0.72
110
118
(4010399)
322
1023
3.49
83.22
1.4
1.4
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
70
45
16.01
81.40
1.1
1.0
u/ml
0.2
0.6
0.38
50
37
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
70
48
15.00
78.65
1.1
1.0
u/ml
1.6
0.6
0.48
52
36
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
69
50
14.19
75.17
1.0
1.0
u/ml
0.4
0.1
1.42
45
30
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
65
43
15.52
74.42
1.1
1.0
u/ml
2.6
8.3
0.32
36
25
(3012494) Peanut IgE Ab [Units/volume] in Serum
84
108
8.03
61.46
1.1
1.1
u/ml
7.7
10.4
0.14
62
69
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
58
45
13.19
60.66
1.1
1.0
u/ml
1.0
0.6
0.14
37
26
(3011897) Casein IgE Ab [Units/volume] in Serum
64
63
10.42
57.43
1.8
1.1
u/ml
19.1
7.2
0.49
22
12
(3000492) Spirometry study
438
1999
2.47
56.87
1.4
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
75
97
7.96
54.58
1.1
1.1
u/ml
20.5
8.7
1.80
35
20
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
52
41
12.95
53.83
1.1
1.0
u/ml
0.3
0.7
0.30
36
27
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
93
157
6.13
52.96
1.2
1.4
u/ml
0.7
0.5
0.24
36
51
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
48
36
13.59
51.15
1.1
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1324
9539
1.90
48.67
4.8
6.6
e9/l
0.2
0.2
8.47
1168
8568
(3019198) Lymphocytes [#/volume] in Blood
1308
9603
1.83
43.02
4.6
6.2
e9/l
1.9
2.0
0.94
1153
8669
(3018010) Neutrophils/100 leukocytes in Blood
1244
9020
1.81
42.39
4.6
6.0
%
54.5
55.9
4.33
1174
8570
(3001604) Monocytes [#/volume] in Blood
1261
9194
1.81
42.05
4.5
6.3
e9/l
0.5
0.5
1.83
1087
8128
(3022096) Basophils/100 leukocytes in Blood
1170
8344
1.81
41.99
4.8
6.4
%
0.7
0.7
1.57
1097
7890
(3002030) Lymphocytes/100 leukocytes in Blood
1256
9152
1.81
41.92
4.8
6.2
%
30.7
30.2
1.25
1181
8681
(3006315) Basophils [#/volume] in Blood
1263
9222
1.81
41.82
4.5
6.3
e9/l
0.0
0.0
0.77
1088
8137
(3006504) Eosinophils/100 leukocytes in Blood
1201
8657
1.80
41.36
4.7
6.3
%
3.4
2.8
11.68
1128
8156
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
40
32
12.70
40.97
1.1
1.0
u/ml
0.8
4.6
0.47
32
16
(3019069) Monocytes/100 leukocytes in Blood
1205
8726
1.79
40.55
4.9
6.4
%
8.0
8.1
0.45
1138
8288
(3020874) Milk IgE Ab [Units/volume] in Serum
90
201
4.62
37.51
1.4
1.1
u/ml
9.4
3.0
0.74
53
71
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
43
9
48.62
35.73
1.1
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
88
203
4.47
35.23
1.3
1.1
u/ml
8.4
1.0
1.35
47
58
(3015076) Soybean IgE Ab [Units/volume] in Serum
85
191
4.58
35.16
1.1
1.1
u/ml
1.3
2.7
0.25
21
32
(42870588) Differential panel, method unspecified - Blood
862
5863
1.75
34.34
4.7
6.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1339
10443
1.66
30.69
6.0
8.9
e9/l
3.7
3.9
6.63
1154
9195
(40768804) Tissue Pathology biopsy report
885
6830
1.48
17.39
1.9
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
273
1617
1.78
16.24
3.2
3.1
%
32.1
31.4
0.58
201
1222
(40758558) Short blood count panel - Blood
604
4403
1.50
15.36
4.6
6.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1495
12918
1.44
15.16
3.5
3.7
mm/h
8.2
8.7
1.11
1406
12116
(3007164) IgA [Mass/volume] in Serum or Plasma
626
4691
1.46
13.59
1.5
1.4
g/l
2.1
2.1
0.32
389
3055
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
691
5315
1.43
12.91
1.8
1.7
pmol/l
101.3
98.8
0.65
359
2962
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2057
19176
1.62
12.48
9.6
10.1
mg/l
18.0
20.1
2.48
1528
14488
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
53
177
3.04
12.47
2.8
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1923
17680
1.50
12.22
4.4
3.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
698
5448
1.40
11.79
1.4
1.4
u/ml
0.9
1.6
3.51
185
1501
(3021589) Normoblasts [#/volume] in Blood
995
8266
1.36
11.29
6.2
8.3
e9/l
0.0
0.0
0.61
776
6756
(3048689) Calprotectin [Mass/mass] in Stool
422
3068
1.46
10.40
2.6
2.6
ug/g
115.5
104.2
0.26
321
2444
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
198
1225
1.67
9.99
1.3
1.2
au/ml
58.9
33.9
—
9
48
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
209
1324
1.64
9.62
2.4
2.3
au/ml
21.9
20.4
0.12
14
115
(3004616) Nuclear Ab [Presence] in Serum
50
188
2.70
9.56
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1826
16858
1.39
9.27
7.8
8.2
ml/min/173m2
95.7
96.4
0.86
1446
13483
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1134
9804
1.31
9.01
3.0
2.9
ug/l
74.0
78.3
0.36
1073
9283
(3022145) Colonoscopy Study observation
255
1724
1.54
8.90
1.3
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
15
25
6.03
8.65
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
190
1217
1.61
8.37
2.9
3.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
121
686
1.81
8.35
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
276
1927
1.49
8.26
1.4
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2029
19171
1.45
8.24
10.3
10.6
%
40.8
40.6
1.08
1809
16127
(40768443) Skin Pathology biopsy report
110
610
1.84
8.16
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
126
730
1.77
8.09
1.4
1.3
—
—
—
0
0
(3013512) EKG study
446
3415
1.38
8.02
2.4
2.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1862
17359
1.36
8.00
4.7
4.5
mu/l
1.7
1.9
0.99
1750
16472
(1002224) Polysomnography panel
153
944
1.66
7.83
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1638
15064
1.29
7.26
4.1
3.9
pmol/l
14.3
14.4
0.54
1514
14026
(44813793)
43
178
2.44
6.86
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
136
849
1.64
6.69
1.8
1.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
50
227
2.23
6.49
1.8
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2257
21995
1.85
6.26
14.1
14.7
e9/l
261.9
262.2
0.10
2213
21502
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
17
43
3.98
6.17
1.1
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
42
184
2.31
5.95
1.5
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
172
1171
1.51
5.84
1.2
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
2257
22023
1.80
5.81
14.0
14.6
fl
89.6
89.5
0.67
2240
21784
(3035941) MCH [Entitic mass]
2257
22023
1.80
5.81
14.0
14.6
pg
30.0
30.0
0.62
2240
21784
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
103
622
1.69
5.79
1.3
1.9
g/l
0.2
0.2
0.77
103
585
(40768797) Stomach Pathology biopsy report
273
2031
1.39
5.78
1.2
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2258
22040
1.80
5.75
14.1
14.7
g/l
137.3
137.1
0.47
2240
21797
(3026361) Erythrocytes [#/volume] in Blood
2257
22029
1.79
5.72
14.0
14.6
e12/l
4.6
4.6
0.11
2210
21511
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
105
641
1.67
5.67
1.3
1.9
g/l
1.2
1.2
0.28
105
604
(3010813) Leukocytes [#/volume] in Blood
2257
22039
1.78
5.57
14.1
14.7
e9/l
6.5
6.7
5.28
2206
21515
(3028192) IgG subclass 2 [Mass/volume] in Serum
46
217
2.14
5.49
1.3
1.4
g/l
2.6
2.7
0.41
39
148
(3024139) IgG subclass 3 [Mass/volume] in Serum
46
217
2.14
5.49
1.3
1.4
g/l
0.3
0.4
0.72
39
148
(3027135) IgG subclass 1 [Mass/volume] in Serum
46
218
2.13
5.43
1.3
1.4
g/l
6.7
6.2
0.37
37
150
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2059
19755
1.36
5.39
9.2
10.3
umol/l
70.3
70.0
0.33
2059
19747
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1493
13792
1.23
5.29
2.8
2.9
u/l
30.6
36.4
4.90
1431
13252
(3019060) Gas panel - Arterial blood
26
626
0.41
5.21
5.0
6.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
750
6469
1.24
5.18
1.8
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1792
16904
1.26
5.16
10.7
12.2
%
13.3
13.4
0.02
1766
16571
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
75
431
1.76
5.07
1.2
1.1
au/ml
30.2
12.7
—
5
37
(4034850)
20
529
0.37
4.99
4.8
7.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
28
111
2.54
4.96
1.1
1.2
—
34.4
—
0
8
(4062490)
45
220
2.07
4.93
1.3
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
821
7179
1.22
4.91
2.3
2.3
nmol/l
76.2
71.6
4.94
757
6737
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
28
112
2.52
4.88
1.1
1.2
—
75.5
—
0
13
(36660697) Celiac disease serology panel - Serum
252
1904
1.36
4.86
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2071
19968
1.34
4.57
7.6
8.2
u/l
26.6
26.8
0.13
2009
19415
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
21
75
2.82
4.55
1.3
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
21
75
2.82
4.55
1.3
1.1
%
92.7
91.1
0.09
21
75
(3029937) Albumin [Presence] in Urine by Test strip
388
4731
0.78
4.53
2.9
3.4
estimate
0.0
0.0
0.29
152
1799
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
22
81
2.73
4.51
1.0
1.2
%
110.7
107.5
0.24
22
68
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
60
1030
0.57
4.49
1.4
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
264
2038
1.33
4.42
1.7
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
68
401
1.72
4.25
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
187
1378
1.39
4.22
2.7
2.1
nmol/l
12.4
12.1
0.17
167
1249
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
317
2540
1.29
4.05
1.6
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1746
16561
1.22
4.03
3.2
3.2
mmol/l
5.5
5.6
7.04
1607
15546
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
147
1048
1.43
4.02
1.3
1.7
mg/l
3.3
4.6
1.03
89
694
(3032773) Endomysium IgG Ab [Titer] in Serum
44
231
1.92
4.02
1.1
1.1
titre
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
208
0.24
3.97
20.2
20.2
nmol/l
1188.2
1427.4
—
5
203
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
53
3.03
3.96
1.0
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
12
358
0.33
3.93
2.3
3.9
mmol/l
1.0
1.4
1.55
12
352
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
233
1798
1.33
3.93
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
48
263
1.84
3.87
1.2
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
20
470
0.42
3.87
2.0
3.6
%
51.6
52.9
0.09
20
465
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
207
0.24
3.80
18.0
14.4
nmol/l
733.2
807.5
—
5
202
(3033658) Prothrombin time (PT) actual/Normal
476
4032
1.23
3.75
3.2
3.9
%
97.3
95.6
0.92
463
3917
(3028026) IgM [Mass/volume] in Serum or Plasma
153
1118
1.39
3.66
1.5
1.9
g/l
1.2
1.3
0.20
134
1057
(3020891) Body temperature
17
417
0.40
3.66
2.6
4.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
71
1105
0.63
3.63
2.5
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
65
400
1.64
3.53
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
395
3303
1.24
3.51
1.3
1.3
iu/ml
20.5
23.3
0.31
96
983
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
114
797
1.45
3.50
1.7
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
623
7059
0.84
3.42
2.6
3.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
86
1267
0.67
3.41
1.4
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1842
17650
1.21
3.40
3.5
3.5
mmol/l
2.9
2.9
0.09
1733
16740
(3005719) IgG [Mass/volume] in Serum or Plasma
190
1457
1.33
3.37
2.1
2.8
g/l
10.5
10.3
0.33
168
1347
(3019150) Specific gravity of Urine by Refractometry
329
3958
0.80
3.34
2.3
3.2
kg/l
1.0
1.0
0.20
49
546
(3002256) Pathology report gross observation
252
2012
1.28
3.33
1.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
168
1271
1.35
3.27
1.2
1.2
titre
33.3
147.8
—
6
30
(3037522) Nuclear Ab [Titer] in Serum
337
2794
1.24
3.24
1.5
1.4
titre
443.1
546.7
0.35
52
524
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1754
16760
1.19
3.20
3.0
3.0
mmol/l
1.2
1.2
1.02
1662
15946
(3024980) IgG subclass 4 [Mass/volume] in Serum
56
342
1.65
3.16
1.5
1.8
g/l
0.6
0.7
0.60
48
258
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
74
484
1.55
3.16
1.2
1.3
u/ml
2.2
11.4
—
8
84
(3028433) Virus identified in Specimen by Culture
17
67
2.55
3.12
1.3
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
82
1194
0.68
3.09
9.1
8.5
mmol/l
0.3
0.8
0.91
67
917
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
26
125
2.09
3.08
1.7
1.6
mg/l
19.4
22.7
—
8
44
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1827
17538
1.19
3.08
3.3
3.3
mmol/l
4.8
4.7
0.19
1733
16758
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
27
132
2.06
3.07
1.3
1.4
mu/l
753.8
441.1
0.85
27
126
(40761536) Microorganisms panel - Urine sediment
126
1696
0.73
3.03
3.8
3.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
22
100
2.21
2.99
1.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1570
14903
1.16
2.96
3.6
4.0
mmol/mol
36.2
37.4
9.58
1489
14183
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
191
1496
1.30
2.94
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
40
228
1.77
2.91
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1866
17971
1.19
2.91
9.1
9.9
mmol/l
3.9
3.9
2.64
1791
17411
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
27
135
2.01
2.90
1.3
1.4
%
73.3
74.1
0.15
27
129
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
32
172
1.87
2.81
1.2
1.1
iu/ml
7.6
8.4
—
7
44
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1815
17457
1.18
2.78
3.3
3.3
mmol/l
1.5
1.5
0.69
1714
16616
(3021447) Carbon dioxide [Partial pressure] in Venous blood
89
1248
0.70
2.76
7.8
5.2
kpa
5.8
5.9
0.08
83
1208
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
71
476
1.51
2.75
1.2
1.3
u/ml
1.4
3.2
—
5
56
(3019550) Sodium [Moles/volume] in Serum or Plasma
1858
17913
1.18
2.73
8.9
9.8
mmol/l
139.6
139.5
0.73
1790
17402
(3036481) Cortisol [Moles/volume] in Serum or Plasma
225
1823
1.26
2.67
2.1
2.0
nmol/l
351.0
375.7
1.25
207
1683
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
464
4044
1.18
2.66
2.2
2.1
mg/l
2.5
2.7
1.28
389
3504
(3002032) Base excess in Venous blood by calculation
89
1238
0.71
2.65
7.6
5.2
mmol/l
1.4
1.6
0.48
72
990
(3000060) B lymphocytes [#/volume] in Blood
21
99
2.13
2.64
1.2
3.0
e6/l
266.9
192.6
0.69
16
61
(3021960) Folate [Moles/volume] in Serum or Plasma
337
2855
1.21
2.64
1.5
1.4
nmol/l
20.3
20.1
0.11
289
2555
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
465
4057
1.18
2.63
2.0
2.0
mg/l
0.7
0.9
1.98
319
2898
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
49
2.66
2.62
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
83
1165
0.70
2.60
1.8
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
74
1060
0.69
2.60
7.1
4.8
kpa
5.0
4.9
0.17
69
1024
(3003740) Influenza virus B Ag [Presence] in Specimen
76
524
1.47
2.58
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
22
107
2.07
2.57
1.1
3.3
u/ml
413.3
777.8
2.40
22
107
(4015189)
8
20
4.01
2.56
1.4
3.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
315
1.60
2.56
1.5
1.7
g/l
3.0
3.1
0.54
40
256
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
603
5386
1.16
2.54
2.3
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
55
356
1.56
2.52
1.2
1.2
—
10.8
—
0
5
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
659
5931
1.15
2.50
2.5
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
449
3926
1.18
2.47
1.5
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1229
11544
1.14
2.46
3.7
3.7
e6/l
4110.0
773.2
0.63
12
124
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
96
2.09
2.43
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
75
523
1.45
2.43
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
39
628
0.61
2.41
1.8
2.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
64
434
1.49
2.39
1.1
1.0
u/ml
5.1
2.3
1.37
35
227
(1761482) Bacteria [#/volume] in Urine by Culture
11
265
0.41
2.37
1.5
3.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
414
3609
1.18
2.36
2.0
2.4
umol/l
4232.3
3509.8
0.14
373
3257
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
76
1062
0.71
2.35
2.3
3.3
mmol/l
1.2
1.2
0.12
67
913
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
362
3122
1.19
2.34
1.3
1.3
u/ml
8.6
9.7
0.16
127
1334
(3024891) Influenza virus A+B Ag [Presence] in Specimen
89
645
1.39
2.34
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
24
127
1.90
2.26
2.8
4.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
155
1228
1.28
2.25
2.4
2.2
ug/l
0.6
0.6
0.12
69
586
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
30
171
1.76
2.25
1.5
2.9
e6/l
943.1
781.6
0.37
11
62
(3045683) HLA typing for celiac disease panel - Blood or Tissue
32
186
1.73
2.24
1.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
161
1282
1.27
2.24
1.9
2.2
e9/l
4.1
4.1
0.02
124
1108
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
453
3995
1.17
2.24
2.2
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1302
12319
1.13
2.23
3.8
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
276
2333
1.21
2.23
2.4
2.6
e6/l
4.5
3.5
0.54
127
1185
(42529406) Shigella sp [Presence] in Stool by Culture
82
594
1.39
2.18
1.1
1.2
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
6
14
4.29
2.15
1.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
330
1.53
2.14
1.5
1.7
g/l
4.0
3.8
0.36
40
249
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
330
1.53
2.14
1.5
1.7
g/l
7.2
7.3
0.11
41
266
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
330
1.53
2.14
1.5
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
84
614
1.38
2.13
3.6
4.4
mmol/l
24.7
24.5
0.15
79
587
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
107
1393
0.76
2.12
2.9
2.6
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
9
208
0.43
2.07
1.3
2.5
mmol/l
1.3
1.4
—
9
202
(3025018) Bordetella pertussis Ab [Titer] in Serum
28
161
1.75
2.06
1.4
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
71
509
1.41
2.03
1.5
1.3
u/l
18.5
19.0
0.04
51
436
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
50
2.41
2.02
1.4
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
89
664
1.35
2.00
3.9
4.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
34
209
1.64
1.98
1.7
3.0
e9/l
1.4
1.3
0.59
19
118
(3014765) Yersinia sp identified in Stool by Organism specific culture
80
590
1.37
1.94
1.1
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
247
2096
1.20
1.94
1.7
1.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
33
2.73
1.93
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
78
575
1.37
1.91
2.3
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
83
1097
0.75
1.86
8.5
9.8
mmol/l
7.5
7.1
0.24
78
1062
(3038177) Helicobacter pylori Ab [Presence] in Serum
57
400
1.44
1.85
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
84
632
1.34
1.82
1.5
1.5
—
—
—
0
0
(4146454)
17
87
1.96
1.79
3.8
2.9
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
29
2.76
1.79
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
109
1.84
1.77
1.3
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
580
5288
1.13
1.76
2.2
2.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
67
2.10
1.76
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
289
1.50
1.75
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
289
1.50
1.75
1.2
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
36
2.51
1.74
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
78
585
1.34
1.74
1.1
1.2
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
7
24
2.92
1.72
1.6
1.8
mg/l
3.0
1.9
—
7
17
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
7
24
2.92
1.72
1.6
1.8
mg/l
1.2
1.3
—
7
19
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
7
24
2.92
1.72
1.6
1.8
mg/l
1.1
1.8
—
7
17
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
7
24
2.92
1.72
1.6
1.8
mg/l
0.5
0.7
—
7
16
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
7
24
2.92
1.72
1.6
1.8
mg/l
1.3
5.3
—
7
15
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
7
24
2.92
1.72
1.6
1.8
mg/l
2.4
1.2
—
7
18
(3019309) Folate [Moles/volume] in Red Blood Cells
233
1992
1.19
1.71
1.5
1.6
nmol/l
903.4
1152.1
4.77
165
1574
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
89
1146
0.77
1.68
1.5
1.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
204
1726
1.20
1.68
1.4
1.4
iu/l
20.5
21.0
0.09
178
1449
(3001019) Free T4 and TSH panel - Serum or Plasma
195
1644
1.20
1.67
1.8
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
19
3.16
1.66
1.5
1.3
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
14
3.58
1.61
1.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
77
584
1.33
1.61
2.2
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
153
1266
1.22
1.59
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
40
578
0.69
1.58
9.9
11.9
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
7
26
2.70
1.58
1.6
1.9
mg/l
1.1
0.7
—
7
18
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
194
1647
1.19
1.56
2.6
3.0
%
18.8
21.4
1.13
45
510
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
12
57
2.11
1.55
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
16
85
1.89
1.55
1.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
14
71
1.98
1.54
2.0
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2075
20382
1.17
1.53
8.3
9.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
262
2286
1.16
1.52
2.0
2.3
umol/l
15.5
14.7
0.89
250
2129
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
321
0.59
1.52
1.4
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
21
2.86
1.50
1.5
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
36
242
1.50
1.50
1.0
1.1
g/l
1.4
1.4
0.50
29
220
(3032080) INR in Blood by Coagulation assay
439
4834
0.89
1.49
4.9
5.6
inr
1.1
1.1
0.26
129
1672
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
14
72
1.95
1.48
1.1
1.1
u/ml
58.3
44.2
0.36
14
72
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
20
116
1.73
1.48
2.1
1.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
59
436
1.36
1.48
1.2
1.2
u/ml
50.0
34.1
—
5
39
(21494755) Public health laboratory ask at order entry panel
352
3149
1.14
1.45
1.3
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
149
1244
1.21
1.44
1.2
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
22
2.73
1.43
1.7
2.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
164
1.59
1.43
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
27
172
1.58
1.43
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
29
189
1.54
1.40
1.3
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
246
2152
1.16
1.40
2.6
2.4
mmol/l
2.4
2.4
0.45
205
1874
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
111
1.72
1.39
1.0
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
24
150
1.61
1.38
1.2
1.4
—
44.0
—
0
5
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
662
6161
1.10
1.37
4.7
5.7
mmol/l
1.2
1.2
1.47
594
5664
(3009214) Lutropin [Units/volume] in Serum or Plasma
131
1087
1.22
1.36
1.5
1.5
u/l
7.4
8.7
1.03
105
888
(3015377) Calcium [Moles/volume] in Serum or Plasma
513
4714
1.11
1.35
2.9
3.0
mmol/l
2.3
2.4
1.19
436
4276
(3024928) Oxygen saturation in Venous blood
16
273
0.58
1.35
23.0
4.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
175
1494
1.19
1.35
1.8
1.6
mu/l
369.0
307.1
0.97
157
1339
(3004789) Transferrin [Mass/volume] in Serum or Plasma
237
2074
1.16
1.35
2.0
2.3
g/l
2.5
2.5
0.22
225
1922
(3018095) Leukocytes [#/volume] in Urine
622
5778
1.10
1.33
3.2
3.4
e6/l
37.8
65.1
1.24
373
3783
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
10
47
2.13
1.33
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
88
1097
0.79
1.33
1.6
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1291
12407
1.09
1.31
6.0
6.6
u/l
70.9
75.1
4.10
1202
11754
(3020630) Protein [Mass/volume] in Serum or Plasma
94
756
1.25
1.31
2.5
2.2
g/l
68.2
67.8
0.27
89
713
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
243
2137
1.15
1.30
3.7
3.1
ug/l
1.3
1.6
1.26
224
1963
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
243
0.57
1.27
1.1
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
90
723
1.25
1.27
1.1
1.1
u/ml
3.9
5.0
0.21
22
116
(3026008) Bacteria identified in Urine by Culture
398
4364
0.89
1.26
2.3
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
186
1.51
1.26
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
150
1273
1.19
1.25
3.0
3.5
%
1.5
1.7
3.03
125
1156
(3041354) Potassium [Moles/volume] in Venous blood
5
116
0.43
1.25
1.2
2.2
mmol/l
3.9
3.9
—
5
116
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
23
147
1.57
1.23
1.1
1.5
g/l
1.0
1.0
0.01
23
147
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
180
1555
1.17
1.22
1.8
2.5
u/l
33.7
70.6
0.62
154
1315
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
453
4923
0.90
1.22
2.2
2.5
u/l
58.3
56.3
0.21
413
4594
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
63
487
1.30
1.22
1.4
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
18
109
1.66
1.18
1.1
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
26
2.31
1.18
1.5
2.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
26
2.31
1.18
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
234
2639
0.87
1.18
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
30
206
1.46
1.17
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
126
0.47
1.16
1.3
1.9
pg
30.0
32.1
—
6
126
(3011288) Drugs identified in Urine by Screen method
167
1441
1.17
1.16
4.5
3.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
43
577
0.74
1.16
1.7
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
30
207
1.46
1.15
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
207
1.46
1.15
1.4
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
87
1.73
1.15
1.8
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
461
4253
1.10
1.14
2.7
2.8
—
—
—
0
0
(4094501)
43
318
1.36
1.13
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
112
0.45
1.13
1.2
6.1
%
8.9
11.7
—
5
112
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
401
0.69
1.12
1.2
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
47
353
1.34
1.12
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
258
0.62
1.12
1.7
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
30
209
1.44
1.10
1.4
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
160
1.51
1.09
1.3
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
25
170
1.48
1.04
1.2
1.4
pmol/l
23.7
70.7
—
7
50
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
214
1899
1.14
1.04
1.2
1.2
iu/ml
132.7
157.1
0.35
70
726
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
103
862
1.20
1.04
3.9
4.3
mmol/l
0.8
1.3
0.91
70
606
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
22
2.28
1.03
1.4
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
211
1873
1.14
1.03
2.1
2.4
%
26.2
24.5
0.93
194
1634
(43055514) Macroprolactin [Presence] in Serum or Plasma
17
106
1.61
1.02
1.1
1.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
25
171
1.47
1.02
1.5
2.7
%
74.1
74.4
0.05
25
166
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
9
47
1.92
1.02
1.0
1.5
u/l
9.1
13.3
—
9
47
(3009343) pH of Capillary blood
105
883
1.20
1.01
4.0
4.3
ph
7.4
7.4
—
8
105
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
14
83
1.69
1.01
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
10
53
1.89
1.01
1.4
1.3
—
71.3
—
0
8
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
155
1.49
1.01
1.5
2.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
853
8941
0.93
1.00
2.7
3.1
estimate
0.0
0.0
1.08
147
1781
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
48
1.88
1.00
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
485
4516
1.09
0.99
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
292
3210
0.90
0.99
3.7
4.3
mg/mmol
11.5
10.8
0.05
168
2139
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
37
274
1.36
0.99
1.1
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
207
1841
1.14
0.99
2.8
3.0
umol/l
5.1
6.6
1.07
181
1553
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
29
0.00
0.97
0.0
7.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
260
0.65
0.97
2.1
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
21
140
1.50
0.97
1.3
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
30
0.00
0.97
0.0
1.3
—
39.7
—
0
23
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
272
2463
1.12
0.97
2.4
2.5
e6/l
0.7
1.2
1.20
121
1314
(3041096) Erythrocytes [Presence] in Urine by Automated
502
5367
0.92
0.97
2.4
2.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
31
0.00
0.96
0.0
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
230
2065
1.13
0.95
1.8
1.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
8.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
32
0.00
0.95
0.0
6.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
77
1.69
0.95
3.7
2.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
105
890
1.19
0.94
4.0
4.3
kpa
5.1
5.2
0.15
100
837
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
29
208
1.40
0.94
1.4
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
62
1.78
0.94
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
64
516
1.25
0.94
2.5
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
113
965
1.18
0.93
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
29
209
1.39
0.92
1.4
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
55
1.82
0.92
1.1
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
55
1.82
0.92
1.1
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
55
1.82
0.92
1.1
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
28
2.15
0.91
1.2
3.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
23
159
1.45
0.91
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
23
159
1.45
0.91
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
23
159
1.45
0.91
1.3
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
877
9156
0.93
0.91
4.1
4.3
mmol/l
6.2
6.3
1.30
796
8286
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
202
1.39
0.89
2.6
3.0
mg/l
24.5
28.6
0.58
23
161
(3034860) Kappa light chains.free [Mass/volume] in Serum
28
202
1.39
0.89
2.7
3.0
mg/l
31.8
67.8
0.60
23
163
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
44
341
1.30
0.89
1.2
1.3
u/ml
2.6
4.9
1.61
20
145
(3030467) Casts [#/volume] in Urine by Automated count
452
4218
1.09
0.89
2.7
2.9
e6/l
0.3
0.3
0.25
309
3090
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
23
160
1.44
0.89
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
23
160
1.44
0.89
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
67
548
1.23
0.88
1.3
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1825
17926
1.08
0.87
11.1
12.3
g/l
333.8
333.8
0.11
1806
17780
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
15
95
1.58
0.87
2.8
3.0
ug/l
0.7
1.1
0.86
15
90
(3025130) Human papilloma virus identified in Specimen
52
414
1.26
0.86
1.7
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
99
1153
0.85
0.83
1.4
2.2
ml/min/173m2
89.3
80.1
2.26
41
417
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
65
1.70
0.82
2.0
3.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
239
2175
1.11
0.81
2.8
4.3
mmol/l
0.8
0.8
1.66
225
2050
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
3.9
—
39.8
—
0
18
(3044007) Cell count panel - Peritoneal fluid
0
24
0.00
0.79
0.0
1.9
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
452
0.77
0.79
1.4
1.9
e6/l
103.2
9121.6
0.59
25
374
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
25
0.00
0.79
0.0
2.4
—
5046.0
—
0
14
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
78
657
1.19
0.78
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
74
1.62
0.78
1.1
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
451
0.77
0.78
1.4
1.9
e6/l
1.8
18.8
2.64
22
356
(4211845)
14
90
1.56
0.78
3.5
2.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
97
0.51
0.78
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
82
1.59
0.78
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
156
1390
1.13
0.76
1.7
1.8
—
—
—
0
0
(44806071)
6
34
1.77
0.76
1.3
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
99
1.52
0.75
4.3
3.6
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
11
67
1.64
0.75
1.3
1.2
u/l
81.7
82.4
0.01
11
59
(3000093) Morphology [Interpretation] in Blood Narrative
18
124
1.46
0.75
1.1
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
77
652
1.19
0.74
1.1
1.3
ug/l
3.3
3.7
0.34
70
615
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
717
6856
1.07
0.74
5.2
6.2
mmol/l
1.2
1.2
2.11
620
5825
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
60
1.67
0.72
1.2
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
13
84
1.55
0.72
1.3
1.1
%
82.8
91.5
—
5
44
(3036489) Thrombin time
84
720
1.17
0.71
2.8
3.0
s
20.7
21.2
1.01
69
617
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
109
1.47
0.71
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
109
1.47
0.71
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
109
1.47
0.71
1.5
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
72
610
1.19
0.70
1.3
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
320
0.75
0.70
1.3
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
34
265
1.29
0.70
1.2
1.3
—
84.0
—
0
5
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
69
1.60
0.68
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
59
1.53
0.68
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
68
576
1.19
0.67
2.1
1.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
45
366
1.23
0.66
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
94
0.53
0.66
1.4
1.8
—
—
—
0
0
(4038314)
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
212
1943
1.10
0.65
3.1
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
863
8935
0.95
0.65
3.9
4.2
estimate
0.0
0.0
0.50
150
1846
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
378
3554
1.08
0.64
2.1
2.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
131
0.61
0.63
3.4
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
131
0.61
0.63
6.8
5.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
129
1.40
0.63
1.1
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
13
87
1.50
0.63
1.0
1.1
%
91.4
92.3
—
5
46
(3012516) Albumin [Mass/volume] in Urine
286
3068
0.92
0.63
3.1
3.5
mg/l
371.0
356.6
0.02
162
2046
(40760888) Immunoglobulin light chains.free panel - Serum
21
155
1.36
0.63
2.2
3.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
34
270
1.26
0.62
1.1
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
22
164
1.34
0.62
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
435
0.80
0.62
1.3
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
105
0.57
0.61
1.5
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
34
271
1.26
0.61
3.3
2.7
nmol/l
24.7
23.5
0.23
34
260
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
13
88
1.48
0.60
1.2
1.1
%
119.1
108.3
0.57
13
83
(3009261) Glucose [Presence] in Urine by Test strip
872
9005
0.95
0.59
2.7
3.1
estimate
0.0
0.0
1.06
147
1781
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
28
355
0.79
0.59
1.8
2.0
ug/l
2.5
2.4
0.02
21
319
(3044941) Cell count panel - Synovial fluid
14
197
0.71
0.58
1.3
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
313
2935
1.08
0.58
2.3
2.6
mosm/kgh2o
552.6
555.4
0.07
258
2526
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
64
1.56
0.58
1.0
1.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
23
0.00
0.58
0.0
7.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
71
614
1.16
0.57
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
782
7553
1.05
0.57
1.9
2.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
29
229
1.27
0.57
1.6
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
484
4616
1.06
0.55
2.7
3.0
e6/l
29.3
83.9
1.49
340
3456
(3050129) First trimester maternal screen panel - Serum or Plasma
157
1718
0.91
0.55
1.4
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
37
1.62
0.55
1.3
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
217
0.74
0.55
1.4
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
544
5678
0.95
0.55
1.7
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
150
1368
1.10
0.54
2.8
3.4
pmol/l
4.7
4.7
0.19
132
1232
(1001926) Buprenorphine [Presence] in Urine by Screen method
179
1647
1.09
0.54
3.4
2.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
40
331
1.21
0.53
2.8
3.2
mg/l
23.7
24.8
0.06
21
206
(3000570) Elastase.pancreatic [Mass/mass] in Stool
49
414
1.19
0.53
1.4
1.4
ug/g
310.3
326.1
0.14
19
211
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
149
1360
1.10
0.53
1.5
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
9
62
1.45
0.53
1.3
1.2
u/l
15.8
13.7
—
9
54
(40768446) Kidney Pathology biopsy report
6
98
0.61
0.52
1.2
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
133
0.68
0.51
1.0
1.1
miu/ml
1096.8
1435.5
—
9
133
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
55
471
1.17
0.51
1.8
2.0
g/l
1.3
1.4
0.27
50
422
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
149
1363
1.10
0.51
1.5
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
162
1488
1.10
0.51
1.5
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
38
456
0.83
0.51
1.2
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.50
1.3
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.50
1.3
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.50
1.3
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.50
1.3
2.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
149
1365
1.10
0.50
1.5
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
77
871
0.88
0.50
4.8
4.2
ug/l
3.5
18.6
1.27
56
647
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
149
1366
1.10
0.49
1.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
125
1136
1.11
0.49
1.5
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
47
551
0.85
0.49
1.2
1.3
—
—
—
0
0
(4024509)
15
110
1.37
0.48
1.7
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
107
0.65
0.48
1.1
1.4
%
—
75.1
—
0
12
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
107
0.65
0.48
2.0
2.8
u/ml
12.6
46.0
—
7
107
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
17
128
1.33
0.47
1.2
1.2
u/l
148.8
57.5
0.47
11
86
(3003694) ABO and Rh group [Type] in Blood
628
6499
0.95
0.46
1.7
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
50
430
1.17
0.46
2.4
2.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
121
1105
1.10
0.45
1.5
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
418
3999
1.06
0.45
1.6
1.6
mmol/l
1.4
1.4
0.16
375
3541
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
71
629
1.13
0.44
1.4
2.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
112
1.34
0.44
2.3
3.9
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
51
1.37
0.44
3.3
2.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
121
1108
1.10
0.43
1.5
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
31
1.61
0.43
1.8
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
384
4014
0.95
0.42
2.9
3.7
ph
7.4
7.4
0.82
58
784
(4035726)
102
1120
0.91
0.42
1.3
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
95
0.63
0.42
1.3
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
23
185
1.25
0.42
1.4
1.4
pmol/l
271.8
378.6
0.91
16
140
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
158
1.27
0.41
1.5
1.8
—
—
—
0
0
(4198724)
16
206
0.78
0.41
3.2
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
265
2797
0.94
0.41
1.5
1.6
pmol/l
405.5
23546582.9
2.20
233
2459
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
33
1.52
0.41
1.6
1.6
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.1
—
16.8
—
0
16
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
16
0.00
0.41
0.0
1.1
—
16.6
—
0
10
(3028717) Thiamine [Mass/volume] in Blood
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
105
1.34
0.41
1.4
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
16
123
1.30
0.40
1.1
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
34
1.47
0.40
1.8
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
132
1.29
0.40
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
30
357
0.84
0.39
1.9
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
29
346
0.84
0.39
2.5
2.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
7
104
0.67
0.39
1.1
7.0
—
130.7
—
0
32
(40765096) Chromosome analysis panel by Banding
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
143
1327
1.08
0.39
4.0
4.4
u/l
216.8
239.8
1.67
135
1265
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
19
0.00
0.39
0.0
4.4
—
6.8
—
0
19
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
19
0.00
0.39
0.0
9.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
160
1.25
0.38
1.5
1.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
19
151
1.26
0.38
2.9
3.1
%
94.0
96.7
0.17
19
144
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
98
1.33
0.37
1.1
1.1
iu/ml
118.8
195.1
1.56
13
98
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
112
0.71
0.37
1.8
2.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
15
116
1.30
0.37
1.0
1.1
—
6.7
—
0
21
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
235
0.81
0.37
1.5
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
499
4823
1.04
0.36
3.1
4.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
180
0.78
0.36
1.4
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
191
0.78
0.36
1.8
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
42
365
1.15
0.36
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
31
364
0.85
0.36
1.5
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
11
81
1.36
0.36
1.6
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
42
1.43
0.35
4.2
6.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
9
126
0.71
0.35
1.1
1.3
—
62.3
—
0
15
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
44
1.36
0.34
1.2
1.2
—
—
—
0
0
(4306422)
40
349
1.15
0.34
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
210
1.19
0.32
1.2
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
45
398
1.13
0.32
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
183
1.20
0.31
1.7
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
221
2104
1.06
0.31
3.1
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
463
4776
0.96
0.31
1.8
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
298
2860
1.05
0.31
2.0
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
813
8301
0.97
0.31
3.6
3.9
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
53
1.32
0.30
1.3
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
98
0.71
0.30
1.3
1.2
—
—
—
0
0
(4281824)
10
131
0.76
0.30
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
32
277
1.16
0.30
1.4
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
54
1.30
0.30
1.3
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
54
1.30
0.30
1.4
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
55
1.27
0.30
1.4
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
260
0.84
0.29
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
67
733
0.91
0.29
1.7
1.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.9
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
220
2101
1.05
0.28
3.1
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
111
0.72
0.28
6.4
7.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
72
661
1.09
0.28
1.1
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
18
216
0.83
0.28
3.4
3.9
u/ml
15.3
24.8
1.53
18
210
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
196
2054
0.95
0.27
2.6
2.3
u/l
9551.7
6438.5
0.35
83
795
(3024561) Albumin [Mass/volume] in Serum or Plasma
610
5959
1.03
0.27
4.2
4.9
g/l
37.5
37.2
0.54
556
5568
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
69
634
1.09
0.27
1.2
1.4
u/ml
222.9
233.3
0.14
39
384
(3000991) Gas panel - Venous blood
107
1142
0.93
0.27
11.2
9.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
22
187
1.18
0.26
1.3
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
25
289
0.86
0.26
1.5
1.6
e6/l
16244.0
10589.6
0.28
18
210
(3051651) Icteric interference index of Serum or Plasma
13
104
1.25
0.26
2.0
3.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
31
352
0.88
0.26
1.3
2.9
nmol/l
1.0
0.8
0.51
26
300
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
765
7796
0.97
0.25
4.9
5.5
umol/l
10.5
10.4
0.13
713
7335
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
149
0.80
0.25
1.3
1.1
u/l
1.0
1.0
—
7
66
(3044927) Protein electrophoresis panel - Urine
9
73
1.23
0.25
1.0
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
24
207
1.16
0.25
1.3
1.3
nmol/l
—
0.4
—
0
8
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
72
666
1.08
0.25
3.0
3.5
%
91.8
94.2
0.46
63
610
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
329
0.88
0.24
2.4
5.1
—
1339.6
—
0
24
(3051611) Lipemic interference index of Serum or Plasma
16
133
1.20
0.24
2.3
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
293
1.13
0.24
1.8
2.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
342
3317
1.04
0.24
3.7
3.9
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
34
380
0.89
0.23
1.5
1.6
mmol/l
7.0
7.4
0.55
24
232
(3037121) Protein [Mass/volume] in Urine
51
557
0.91
0.23
1.7
4.2
g/l
0.2
0.3
2.30
18
283
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
179
0.84
0.23
1.3
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
342
1.11
0.23
1.2
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
14
168
0.83
0.22
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
736
7232
1.03
0.22
2.1
2.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
95
0.74
0.22
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
21
242
0.87
0.22
1.4
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
105
992
1.06
0.22
1.8
1.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
42
1.19
0.21
1.4
1.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
4.7
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
11
0.00
0.21
0.0
1.3
—
70.8
—
0
11
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
10
0.00
0.21
0.0
1.2
—
32.8
—
0
10
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806420)
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
383
3930
0.97
0.21
2.6
3.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
102
0.78
0.21
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
154
1.17
0.21
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
222
2300
0.96
0.21
2.5
3.1
ng/l
1131.7
612.3
0.33
168
1840
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
50.1
—
0
7
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
145
1.17
0.20
1.2
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
123
0.81
0.20
1.4
1.7
—
1081665.0
—
0
10
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.4
—
317.1
—
0
14
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
50
1.20
0.19
1.3
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.3
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.3
2.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
146
1.17
0.19
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
52
1.15
0.19
1.3
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
216
2089
1.04
0.19
3.1
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1057
10687
0.98
0.18
2.5
2.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
132
0.83
0.18
1.5
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
58
1.21
0.18
1.3
1.4
ug/l
8.0
8.0
—
7
58
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
336
3278
1.03
0.18
1.5
1.8
%
1.3
1.4
1.91
300
2985
(3021879) Hepatitis B virus core Ab [Presence] in Serum
236
2289
1.03
0.18
1.4
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
153
0.85
0.18
1.5
1.6
%
45.0
53.0
—
6
105
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
252
1.11
0.17
1.4
1.8
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
61
1.15
0.17
2.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
31
341
0.91
0.17
1.4
1.5
mmol/l
6.3
6.7
0.39
24
241
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
38
349
1.09
0.17
1.2
1.3
u/ml
1.3
4.9
2.41
12
116
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
67
0.75
0.17
1.0
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
68
0.73
0.17
1.0
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
29
319
0.91
0.16
1.4
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
69
1.16
0.16
1.0
1.1
u/l
5.3
21.5
—
8
53
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
177
1.13
0.16
1.2
1.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
71
1.13
0.16
1.0
1.1
u/l
59.0
89.5
—
8
56
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
76
0.79
0.15
1.0
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
468
4763
0.98
0.15
2.2
2.6
ng/l
15.7
31.6
2.66
190
2144
(3025159) Blasts/100 leukocytes in Blood
131
1261
1.04
0.15
3.6
4.8
%
0.0
0.4
0.68
21
281
(3034426) Prothrombin time (PT)
6
80
0.75
0.15
1.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
10
119
0.84
0.15
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
16
182
0.88
0.15
2.4
1.2
u/l
70.1
36.4
0.23
16
160
(3021440) Promyelocytes/100 leukocytes in Blood
137
1321
1.04
0.15
3.6
4.7
%
0.1
0.1
0.38
23
327
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
36
333
1.08
0.14
1.1
1.1
%
109.8
115.7
0.48
29
306
(3028707) Methadone [Presence] in Urine by Screen method
94
900
1.05
0.14
5.2
3.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
189
1.11
0.13
1.2
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
98
0.82
0.13
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
212
2066
1.03
0.13
2.2
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
21
232
0.90
0.13
1.4
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
110
1141
0.96
0.13
10.0
12.3
inr
1.1
1.1
0.17
21
199
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
9
110
0.82
0.13
2.2
2.5
umol/l
53.2
50.0
—
9
99
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
136
1317
1.03
0.13
2.8
2.6
g/l
0.2
0.2
0.15
128
1238
(3023520) Reticulocytes [#/volume] in Blood
89
855
1.04
0.12
2.5
3.2
e9/l
65.9
73.2
1.35
59
599
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
179
0.89
0.12
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
12
137
0.88
0.12
1.8
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
384
3901
0.98
0.11
1.9
2.1
u/l
172.2
216.0
0.55
363
3718
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
168
0.89
0.11
1.3
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
261
0.92
0.11
2.0
2.3
%
18.6
17.5
—
8
131
(3002179) Metamyelocytes/100 leukocytes in Blood
132
1281
1.03
0.11
2.9
4.3
%
0.4
0.6
0.65
19
268
(3003458) Phosphate [Moles/volume] in Serum or Plasma
171
1754
0.97
0.11
4.2
7.1
mmol/l
1.1
1.1
0.22
156
1659
(3021901) Oxygen saturation in Capillary blood
18
198
0.91
0.10
4.8
3.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
92
951
0.97
0.10
1.5
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
134
1305
1.03
0.10
1.3
1.3
miu/ml
242.2
235.0
0.08
63
655
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
241
2366
1.02
0.10
3.0
2.9
ng/l
1057.6
576.0
0.27
119
1288
(3009508) Creatinine [Moles/volume] in Urine
428
4335
0.98
0.10
3.4
3.5
mmol/l
8.1
8.6
1.21
371
3801
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
46
1.09
0.09
2.4
2.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
114
0.88
0.09
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
57
546
1.05
0.09
1.2
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
145
1.10
0.09
2.1
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
29
309
0.94
0.09
1.5
2.2
g/l
132.8
135.1
0.19
15
237
(3012501) Base excess in Blood by calculation
33
311
1.06
0.09
2.5
3.4
mmol/l
1.8
2.2
0.46
15
174
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
233
1.07
0.09
1.3
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
58
1.03
0.08
1.2
1.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
5
61
0.82
0.08
1.4
1.4
—
4.2
—
0
14
(21494814) CD8 cells/100 lymphocytes in Specimen
5
63
0.79
0.08
2.2
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
195
0.92
0.08
1.3
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
123
0.89
0.08
1.3
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
31
293
1.06
0.08
1.4
2.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
215
1.07
0.07
1.3
1.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
8
76
1.05
0.07
1.0
1.1
—
5.0
—
0
7
(3039162) Centromere protein B Ab [Units/volume] in Serum
26
245
1.06
0.07
1.1
1.3
—
32.3
—
0
17
(3020876) Protein [Mass/time] in 24 hour Urine
9
85
1.06
0.07
2.8
2.0
—
1.7
—
0
8
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
140
1373
1.02
0.07
1.5
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
265
1.06
0.07
3.1
5.7
u/ml
0.4
0.4
0.06
18
130
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
10
89
1.12
0.07
1.4
1.5
u/l
0.8
3.9
—
5
43
(3036603) Volume of Urine
8
95
0.84
0.06
1.3
1.6
—
2240.6
—
0
16
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
89
912
0.97
0.06
2.9
4.7
ng/l
62.5
73.2
1.24
83
834
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
99
1.11
0.06
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
36
376
0.96
0.06
1.4
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
105
0.86
0.06
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
38
365
1.04
0.06
2.4
3.4
ph
7.4
7.4
0.72
33
309
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
74
759
0.97
0.06
1.7
2.0
ug/l
4.2
7.2
1.83
67
682
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
57
587
0.97
0.05
1.6
1.5
nmol/l
0.5
0.4
0.20
52
478
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
137
1350
1.02
0.04
1.5
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
140
1.07
0.04
1.5
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
71
725
0.98
0.04
1.6
1.6
iu/ml
0.0
0.1
—
10
138
(3023410) Appearance of Cerebral spinal fluid
23
220
1.05
0.03
1.7
2.6
—
—
—
0
0
(4268621)
25
240
1.04
0.03
1.9
2.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
16
151
1.06
0.03
1.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
37
381
0.97
0.03
1.9
3.9
e9/l
4.1
3.9
0.29
37
381
(3004716) Salmonella sp identified in Stool by Organism specific culture
156
1576
0.99
0.03
1.4
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
179
0.95
0.03
1.7
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
101
1023
0.99
0.03
1.4
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
56
571
0.98
0.03
1.8
2.0
iu/l
3.3
4.6
1.45
17
234
(3045142) Bone marrow Pathology biopsy report
13
122
1.07
0.02
1.7
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
612
6139
1.00
0.02
2.6
3.2
u/l
27.7
30.1
1.47
585
5873
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
178
0.95
0.02
1.7
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
371
1.02
0.02
1.3
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
212
1.04
0.02
1.6
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
42
429
0.98
0.02
1.5
2.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
316
3147
1.00
0.02
2.2
2.5
e6/l
7.1
7.7
0.25
262
2775
(3022621) pH of Urine by Test strip
103
1040
0.99
0.02
2.3
2.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
12
127
0.94
0.01
2.3
3.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
177
0.96
0.01
1.2
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
183
1.04
0.01
1.3
1.3
nmol/l
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
139
1381
1.01
0.01
3.6
4.7
%
0.8
0.9
0.13
24
354
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
25
243
1.03
0.01
1.4
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
247
2480
1.00
0.01
2.1
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
387
0.98
0.01
1.9
4.2
%
56.3
55.5
0.19
38
387
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
94
1.06
0.01
1.3
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
12
114
1.05
0.00
1.1
1.1
%
93.6
92.9
—
7
92
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
156
0.96
0.00
4.1
3.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
184
1.03
0.00
1.1
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
30
306
0.98
0.00
2.3
3.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
110
1094
1.01
0.00
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
205
0.98
0.00
1.4
1.1
—
—
—
0
0
(44790049)
22
215
1.02
0.00
1.3
1.6
—
—
—
0
0
(44790048)
22
215
1.02
0.00
1.3
1.6
—
—
—
0
0
(44790047)
22
215
1.02
0.00
1.3
1.6
—
—
—
0
0
(44806118)
22
215
1.02
0.00
1.3
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
68
685
0.99
0.00
2.7
2.8
ng/l
100.1
94.5
0.09
56
589
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
83
835
0.99
0.00
1.6
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
521
1.00
0.00
1.2
1.5
u/ml
79.7
103.5
—
8
97
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
96
1.04
0.00
1.2
1.1
—
—
—
0
0
(4027681)
18
184
0.98
0.00
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
359
3585
1.00
0.00
1.5
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
37
374
0.99
0.00
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
29
287
1.01
0.00
1.9
3.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
28
283
0.99
0.00
1.1
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
34
343
0.99
0.00
1.1
1.1
iu/ml
165.9
1295.6
—
9
108
(3034274) Bile acid [Moles/volume] in Serum --fasting
59
593
0.99
0.00
2.8
2.5
umol/l
5.6
5.7
0.03
44
447
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
154
1537
1.00
0.00
3.6
4.7
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
3.3
—
0
6
(3047185) IgG [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
0.3
—
0
5
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
114.2
—
0
5
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
120
1.00
0.00
1.3
1.6
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
3.1
—
0
5
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
59
0.85
0.00
1.0
1.3
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
51
0.98
0.00
1.2
2.3
ug/l
87.4
70.5
—
5
51
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
3.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
75
0.93
0.00
1.1
2.8
—
—
—
0
0
(4133840)
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
8
0.00
0.00
0.0
1.6
—
2.2
—
0
8
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
202
2020
1.00
0.00
2.4
2.6
s
29.4
29.5
0.12
195
1957
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
77
0.91
0.00
1.4
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
89
0.90
0.00
1.8
1.3
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
3.8
—
0
5
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
75
0.93
0.00
1.1
2.8
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
30.3
—
0
7
(3003157) Bacteria [#/volume] in Mother's milk
0
9
0.00
0.00
0.0
8.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
1.5
—
0
9
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
58
0.86
0.00
1.4
1.1
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
69
1.01
0.00
1.1
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
57
0.88
0.00
1.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
72
0.97
0.00
1.6
2.2
umol/l
15.8
16.4
—
7
72
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_DESEN_ALLERGE – Desensitization to allergens
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).